TIGIT and neoplasm: The poliovirus receptor (PVR or CD155), a member of the adhesion molecule family, serves as a ligand for TIGIT and is highly expressed on the surface of various tumor cells, inhibiting the activation of T and NK cells, thus promoting tumor metastasis and progression [14, 15].